ADARx Pharmaceuticals, Inc.

US$13.23As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ADRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$1.483B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$16
17.49%
(51.02%)
Hold 7|11|9|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.15
0.15
0.15
0.77%
3.51%
3.75%
2.06%
Revenue$M
85.21
83.98
83.68
82.11
4.57%
1.26%
0.57%
(5.25%)
Peers (US$1.483B)
Cap (US$)
PE
1.469B
—
Capital
TTM
5Y
10Y
Leveragex
0.119
0.118
0.119
EBIT/Intx
0.212
0.581
0.620
Own earn%
(10.51)
2.37
7.86
Sh yield%
22.88
40.70
40.80
Owners
Insiders/Inst%
6.98
75.40
Short interest%
1.53
SBC / revenue%
5.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
20–27
$1 testx
0.0
Incr. ROIC%
2